Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bacterial Vaginosis - Overview
Bacterial Vaginosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Bacterial Vaginosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bacterial Vaginosis - Companies Involved in Therapeutics Development
Dare Bioscience Inc
Evofem Biosciences Inc
Hammock Pharmaceuticals Inc
Hennepin Life Sciences LLC
Melinta Therapeutics Inc
Next Science Ltd
Osel Inc
PhagoMed Biopharma GmbH
Pharmiva AB
Profem GmbH
Starpharma Holdings Ltd
Suzhou Ousai Weike Biomedical Technology Co Ltd
TenNor Therapeutics Ltd
Toltec Pharmaceuticals LLC
Bacterial Vaginosis - Drug Profiles
(citric acid + lactic acid + potassium bitartrate) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
astodrimer - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biologic for Bacterial Vaginosis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Bacterial Vaginosis - Dormant Projects
Bacterial Vaginosis - Discontinued Products
Bacterial Vaginosis - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Bacterial Vaginosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development for Bacterial Vaginosis, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Bacterial Vaginosis - Pipeline by Dare Bioscience Inc, H2 2020
Bacterial Vaginosis - Pipeline by Evofem Biosciences Inc, H2 2020
Bacterial Vaginosis - Pipeline by Hammock Pharmaceuticals Inc, H2 2020
Bacterial Vaginosis - Pipeline by Hennepin Life Sciences LLC, H2 2020
Bacterial Vaginosis - Pipeline by Melinta Therapeutics Inc, H2 2020
Bacterial Vaginosis - Pipeline by Next Science Ltd, H2 2020
Bacterial Vaginosis - Pipeline by Osel Inc, H2 2020
Bacterial Vaginosis - Pipeline by PhagoMed Biopharma GmbH, H2 2020
Bacterial Vaginosis - Pipeline by Pharmiva AB, H2 2020
Bacterial Vaginosis - Pipeline by Profem GmbH, H2 2020
Bacterial Vaginosis - Pipeline by Starpharma Holdings Ltd, H2 2020
Bacterial Vaginosis - Pipeline by Suzhou Ousai Weike Biomedical Technology Co Ltd, H2 2020
Bacterial Vaginosis - Pipeline by TenNor Therapeutics Ltd, H2 2020
Bacterial Vaginosis - Pipeline by Toltec Pharmaceuticals LLC, H2 2020
Bacterial Vaginosis - Dormant Projects, H2 2020
Bacterial Vaginosis - Discontinued Products, H2 2020